|
FROM INLICENSING INTO INDIA TO
OUTLICENSING TO THE WORLD.
Past
Created Markets in India
Oncology - Cyclophosphamide, Cisplatin, Bleomycin - Nippon
Kayaku(Japan) / Asta Medica (Germany).
Pain and Spasm – Camylofin and Methocarbamol - Asta Medica /
A.H.Robins (USA).
Anaesthetic – Glycopyrrolate – A.H. Robins
Respiratory Stimulants – Doxapram – A.H. Robins.
Iron Supplements – Iron Polymaltose – Hausmann Laboratories(Switzerland).
Anti-tussive – Prenoxdiazine – Chinoin (Hungary) |
|
||||||||||||||
|
Present
Introduced Patented Products
based on NDDS
(Marketed in India and out-Licensed for the Developing Countries)
Camylofin combinations with Nimesulide/ Diclofenac –
ANAFORTANGROUP
Methocarbamol combinations with Diclofenac / Nimesulide.-
ROBI GROUP
Cefixime once a day - CEFI OD.
Cefixime + Cloxacillin + Lactobacillus - CEFI XL. |
||||||||||||||||
|
Future
Patents driven by NDDS, Nano
and Dendrimers
(To be marketed in India and to be out Licensed to the developed countries)
Silver Nano Gel for burns, wounds, acne etc.
Gold Nano Gel for cosmetics.
Dendrimers for cosmetics, antimicrobials etc.
Parenterals to Oral Delivery
Colon / Brain and Site Specific Targeting |
||||||||||||||||
